Anti-Cholinesterase Potential of Standardized Extract of PHELA a Traditional South African Medicine Formulation

Adewusi, 2012, Cytotoxicity and acetylcholinesterase inhibitory activity of isolated crinine alkaloid from Boophanedisticha (Amaryllidaceae), J. Ethnophar., 143, 572, 10.1016/j.jep.2012.07.011 Alzheimer’s disease International, 2015 Bhadra, 2011, Anticholinesterase activity of standardized extract of Illicium verum Hook.f. fruits, Fitoterapia, 82, 342, 10.1016/j.fitote.2010.11.003 Bolognesi, 2009, Alzheimer’s disease: new approaches to drug discovery, Curr. Opin. Chem. Biol., 13, 303, 10.1016/j.cbpa.2009.04.619 Chung, 2001, Inhibitory Effect of Ursolic acid purified from OriganummajoranaL. on the Acetylcholinesterase, Mol. Cells., 11, 137 Cummings, 2000, Cognitive and behavioral heterogeneity in Alzheimer’s disease: Seeking the neurobiological basis, Neurobiol. Aging., 21, 845, 10.1016/S0197-4580(00)00183-4 Dong, 2016, Emodin: A review of its pharmacology, toxicity and pharmacokinetics, Phytother. Res., 30, 1207, 10.1002/ptr.5631 Gutzmann, 1998, Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre study, J. Neural.Transm. Suppl., 54, 301, 10.1007/978-3-7091-7508-8_30 Halliwell, 1987, The deoxyribose method: a simple “test-tube” assay for determination of rate constants for reactions of hydroxyl radicals, Anal. Biochem., 165, 215, 10.1016/0003-2697(87)90222-3 Heo, 2001, Ursolic Acid of OriganummajoranaL. Reduces Aâ-induced Oxidative, Injury. Mol. Cells., 13, 5 Homor, 1987, Acetylcholinesteraseresynthesis after DFP poisoning: histochemical and biochemical study, ActaHistochem., 62, 293 Lee, 2017, In vitro assessment of selected Korean plants for antioxidant and antiacetylcholinesterase activities, Pharm Biol., 55, 2205, 10.1080/13880209.2017.1397179 Lekhooa, 2012, Evaluation of Traditional Medicines III: The Mechanism of Immune Modulation by PHELA, Afr. J. Tradit. Compl. Alt. Med., 9, 47 Lekhooa, 2017, The development and use of a drug-induced immunosuppressed rat-model to screen Phela for mechanism of immune stimulation, J. Ethnopharmacol., 12, 8, 10.1016/j.jep.2017.04.031 Liang, 2016, Ursolic acid attenuates beta-amyloid-induced memory impairment in mice, Arq. Neuro-Psiquiatr., 74, 482, 10.1590/0004-282x20160065 Mangialasche, 2010, Alzheimer’s disease: clinical trials and drug development, Lancet. Neurol., 9, 702, 10.1016/S1474-4422(10)70119-8 Mohandas, 2009, Neurobiology of Alzheimer’s disease, Indian. J. Psychiatry, 51, 55, 10.4103/0019-5545.44908 Mukherjee, 2019, 377 Nwidu, 2018, In Vitro Anti-Cholinesterase and Antioxidant Activity of Extracts of Moringa oleifera Plants from Rivers State, Niger Delta, Nigeria, Medicines, 5, 1, 10.3390/medicines5030071 Patel, 2013, Development and Validation of Stability Indicating HPTLC Method for Estimation of Ursolic Acid, Asian J. Res. Chem., 6, 546 Perry, 1978, Changes in brain cholinesterases in senile dementia of Alzheimer type, Neuropathol. Appl. Neurobiol., 4, 273, 10.1111/j.1365-2990.1978.tb00545.x Price, 1986, New perspectives on Alzheimer's disease, Annu Rev Neurosci ., 9, 489, 10.1146/annurev.ne.09.030186.002421 Quettier, 2000, Phenolic compounds and antioxidant activities of buckwheat (FagopyrumesculentumMoench) hulls and flour, J. Ethnopharmacol., 72, 35, 10.1016/S0378-8741(00)00196-3 Reyes-García, 2009, A neurotransmitter system that regulates macrophage pro-inflammatory functions, J. Neuroimmunol., 216, 20, 10.1016/j.jneuroim.2009.06.024 Rhee, 2001, Screening for acetylcholinesterase inhibitors from Amaryllidaceae using sílica gel thin-layer chromatography in combination with bioactivity staining, J. Chromatogr. A., 915, 217, 10.1016/S0021-9673(01)00624-0 Stanković, 2011, Total phenolic content, flavonoid concentration and Antioxidant activity of Marrubiumperegrinum L. Extracts, Kragujevac J. Sci., 33, 63 Sun, 2015, Blockade of emodin on amyloid-β 25-35-induced neurotoxicity in AβPP/PS1 mice and PC12 cells through activation of the class III phosphatidylinositol 3-kinase/Beclin-1/B-cell lymphoma 2 pathway, Planta Med., 81, 108, 10.1055/s-0034-1383410 Szelényi, 2001, Cytokines and the central nervous system, Brain Res. Bull., 54, 329, 10.1016/S0361-9230(01)00428-2 Taylor, 2004, The healing power of rainforest herbs. New York: Square One Publishers, Inc, 243 Vaz, 2011, Chemical composition of wild edible mushrooms and antioxidant properties of their water soluble polysaccharidic and ethanolic fractions, Food Chem., 126, 610, 10.1016/j.foodchem.2010.11.063 Vina, 2011, Antioxidant pathways in Alzheimer’s disease: possibilities of intervention, Curr. Pharm. Des., 17, 3861, 10.2174/138161211798357755 Weiner, 2006, Immunology and immunotherapy of Alzheimer’s disease, Nature Reviews Immunology., 6, 404, 10.1038/nri1843 Wozniak, 2015, Ursolic acid-A pentacyclictriterpenoid with wide spectrum of pharmacological activities, Molecules, 20, 20614, 10.3390/molecules201119721